Simplifying contrast-induced acute kidney injury prediction after primary percutaneous coronary intervention: the age, creatinine and ejection fraction score

[1]  Usha Govindarajulu,et al.  Comparison of Two Risk Models in Predicting the Incidence of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention. , 2016, Journal of interventional cardiology.

[2]  D. Capodanno,et al.  Risk prediction of contrast-induced nephropathy by ACEF score in patients undergoing coronary catheterization , 2016, Journal of cardiovascular medicine.

[3]  N. Tan,et al.  Comparison of Different Risk Scores for Predicting Contrast Induced Nephropathy and Outcomes After Primary Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction. , 2016, The American journal of cardiology.

[4]  F. Lombardi,et al.  A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2016, International journal of cardiology.

[5]  S. Raposeiras-Roubín,et al.  Mehran contrast nephropathy risk score: Is it still useful 10 years later? , 2016, Journal of cardiology.

[6]  Michael E. Matheny,et al.  Acute Kidney Injury Risk Prediction in Patients Undergoing Coronary Angiography in a National Veterans Health Administration Cohort With External Validation , 2015, Journal of the American Heart Association.

[7]  A. Sato,et al.  Effect of the Mehran risk score for the prediction of clinical outcomes after percutaneous coronary intervention. , 2015, Journal of cardiology.

[8]  M. Jeong,et al.  Prognostic value of the age, creatinine, and ejection fraction score for 1-year mortality in 30-day survivors who underwent percutaneous coronary intervention after acute myocardial infarction. , 2015, The American journal of cardiology.

[9]  D. Mozaffarian,et al.  Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial , 2015, Journal of the American Heart Association.

[10]  L. Fauchier,et al.  Predictive factors of contrast-induced nephropathy in patients undergoing primary coronary angioplasty. , 2014, Archives of cardiovascular diseases.

[11]  G. Montalescot,et al.  Contrast-induced nephropathy: the sin of primary percutaneous coronary intervention? , 2014, European heart journal.

[12]  Yibo He,et al.  Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention , 2014, International Urology and Nephrology.

[13]  D. Şahin,et al.  Contrast-Induced Nephropathy in Patients With ST Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention , 2014, Angiology.

[14]  G. Andò,et al.  Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast‐induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[15]  C. Marcantoni,et al.  Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention. , 2013, International journal of cardiology.

[16]  H. Gurm,et al.  A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention. , 2013, Journal of the American College of Cardiology.

[17]  D. Stakos,et al.  Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice. , 2013, International journal of cardiology.

[18]  M. Tonelli,et al.  Contrast-Induced Acute Kidney Injury and Risk of Adverse Clinical Outcomes After Coronary Angiography: A Systematic Review and Meta-Analysis , 2013, Circulation. Cardiovascular interventions.

[19]  J. Wi,et al.  Prediction of Contrast‐Induced Nephropathy With Persistent Renal Dysfunction and Adverse Long‐term Outcomes in Patients With Acute Myocardial Infarction Using the Mehran Risk Score , 2013, Clinical cardiology.

[20]  Wim Van Biesen,et al.  A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy† , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  B. Régnier,et al.  Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. , 2011, Journal of critical care.

[22]  Dick M. Goedhart,et al.  Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the ‘All-Comers' LEADERS Trial , 2011, Circulation. Cardiovascular interventions.

[23]  G. Sangiorgi,et al.  Mehran Contrast-Induced Nephropathy Risk Score Predicts Short- and Long-Term Clinical Outcomes in Patients With ST-Elevation–Myocardial Infarction , 2010, Circulation. Cardiovascular interventions.

[24]  G. Pelissero,et al.  Risk of Assessing Mortality Risk in Elective Cardiac Operations: Age, Creatinine, Ejection Fraction, and the Law of Parsimony , 2009, Circulation.

[25]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[26]  K. Harjai,et al.  Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. , 2004, The American journal of cardiology.

[27]  Kirk N. Garratt,et al.  Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.

[28]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[29]  F H Sheehan,et al.  The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. , 1987, Circulation.

[30]  M. Moscucci.  Contrast-induced acute kidney injury: the continuous quest for pharmacological prevention. , 2012, Circulation. Cardiovascular interventions.

[31]  M. Rudnick,et al.  Contrast-induced nephropathy: what are the true clinical consequences? , 2008, Clinical journal of the American Society of Nephrology : CJASN.